stars 1 stars 2 stars 3

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom.

View Top Employees from CRISPR Therapeutics
Website http://www.crisprtx.com
Ticker CRSP
Revenue $289 million
Funding $56 million
Employees 539 (539 on RocketReach)
Founded 2013
Address 105 West First Street, Boston, Massachusetts 02127, US
Phone +41 41 561 32 77
Technologies
Industry Biotechnology Research, Pharmaceuticals, Biopharma, Healthcare, Biotechnology, Health Care, Science and Engineering, Genetics, Medical
Web Rank 1 Million
Keywords Gene Editing, Therapeutic Activities, Oncology, Regenerative Agriculture, Rare Disease
Competitors Anthera Pharmaceuticals, Applied StemCell, Editas Medicine, Intellia Therapeutics, Inc., Sage Therapeutics
SIC SIC Code 87 Companies, SIC Code 37 Companies
NAICS NAICS Code 541 Companies, NAICS Code 33 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541711 Companies

CRISPR Therapeutics Questions

The CRISPR Therapeutics annual revenue was $289 million in 2024.

Phuong Morrow is the Chief Medical Officer of CRISPR Therapeutics.

539 people are employed at CRISPR Therapeutics.

CRISPR Therapeutics is based in Boston, Massachusetts.

The NAICS codes for CRISPR Therapeutics are [541, 33, 54, 54171, 5417, 541711].

The SIC codes for CRISPR Therapeutics are [87, 37].

Top CRISPR Therapeutics Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users